103 related articles for article (PubMed ID: 15178447)
1. Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.
Trotzier MA; Bronner C; Bathami K; Mathieu E; Abbady AQ; Jeanblanc M; Muller CD; Rochette-Egly C; Mousli M
Biochem Biophys Res Commun; 2004 Jun; 319(2):590-5. PubMed ID: 15178447
[TBL] [Abstract][Full Text] [Related]
2. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
Hopfner R; Mousli M; Jeltsch JM; Voulgaris A; Lutz Y; Marin C; Bellocq JP; Oudet P; Bronner C
Cancer Res; 2000 Jan; 60(1):121-8. PubMed ID: 10646863
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.
Arima Y; Hirota T; Bronner C; Mousli M; Fujiwara T; Niwa S; Ishikawa H; Saya H
Genes Cells; 2004 Feb; 9(2):131-42. PubMed ID: 15009091
[TBL] [Abstract][Full Text] [Related]
4. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression.
Hopfner R; Mousli M; Garnier JM; Redon R; du Manoir S; Chatton B; Ghyselinck N; Oudet P; Bronner C
Gene; 2001 Mar; 266(1-2):15-23. PubMed ID: 11290415
[TBL] [Abstract][Full Text] [Related]
5. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.
Jeanblanc M; Mousli M; Hopfner R; Bathami K; Martinet N; Abbady AQ; Siffert JC; Mathieu E; Muller CD; Bronner C
Oncogene; 2005 Nov; 24(49):7337-45. PubMed ID: 16007129
[TBL] [Abstract][Full Text] [Related]
6. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.
Mousli M; Hopfner R; Abbady AQ; Monté D; Jeanblanc M; Oudet P; Louis B; Bronner C
Br J Cancer; 2003 Jul; 89(1):120-7. PubMed ID: 12838312
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of ICBP90 contributes to doxorubicin resistance.
Wang J; Song Y; Xu S; Zhang Q; Li Y; Tang D; Jin S
Eur J Pharmacol; 2011 Apr; 656(1-3):33-8. PubMed ID: 21296067
[TBL] [Abstract][Full Text] [Related]
8. Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
Morgan SE; Beck WT
Mol Pharmacol; 2001 Feb; 59(2):203-11. PubMed ID: 11160854
[TBL] [Abstract][Full Text] [Related]
9. TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.
Abbady AQ; Bronner C; Bathami K; Muller CD; Jeanblanc M; Mathieu E; Klein JP; Candolfi E; Mousli M
Biochem Pharmacol; 2005 Aug; 70(4):570-9. PubMed ID: 15964557
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.
Hopfner R; Mousli M; Oudet P; Bronner C
Anticancer Res; 2002; 22(6A):3165-70. PubMed ID: 12530060
[TBL] [Abstract][Full Text] [Related]
11. The antiapoptotic protein ICBP90 is a target for protein kinase 2.
Bronner C; Trotzier MA; Filhol O; Cochet C; Rochette-Egly C; Schöller-Guinard M; Klein JP; Mousli M
Ann N Y Acad Sci; 2004 Dec; 1030():355-60. PubMed ID: 15659817
[TBL] [Abstract][Full Text] [Related]
12. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.
Unoki M; Nishidate T; Nakamura Y
Oncogene; 2004 Oct; 23(46):7601-10. PubMed ID: 15361834
[TBL] [Abstract][Full Text] [Related]
13. Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells.
Chen MC; Chen CH; Chuang HC; Kulp SK; Teng CM; Chen CS
Hepatology; 2011 Jan; 53(1):148-59. PubMed ID: 21254166
[TBL] [Abstract][Full Text] [Related]
14. ICBP90 mediates the ERK1/2 signaling to regulate the proliferation of Jurkat T cells.
Fang Z; Xing F; Bronner C; Teng Z; Guo Z
Cell Immunol; 2009; 257(1-2):80-7. PubMed ID: 19328461
[TBL] [Abstract][Full Text] [Related]
15. The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIalpha gene by heat shock.
Furukawa M; Uchiumi T; Nomoto M; Takano H; Morimoto RI; Naito S; Kuwano M; Kohno K
J Biol Chem; 1998 Apr; 273(17):10550-5. PubMed ID: 9553115
[TBL] [Abstract][Full Text] [Related]
16. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
Adachi N; Nomoto M; Kohno K; Koyama H
Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
[TBL] [Abstract][Full Text] [Related]
17. ATF is important to late S phase-dependent regulation of DNA topoisomerase IIalpha gene expression in HeLa cells.
Son MY; Kim TJ; Kweon KI; Park JI; Park C; Lee YC; No Z; Ahn JW; Yoon WH; Park SK; Lim K; Hwang BD
Cancer Lett; 2002 Oct; 184(1):81-8. PubMed ID: 12104051
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase IIalpha promoter.
Flores LV; Staples AM; Mackay H; Howard CM; Uthe PB; Sexton JS; Buchmueller KL; Wilson WD; O'Hare C; Kluza J; Hochhauser D; Hartley JA; Lee M
Chembiochem; 2006 Nov; 7(11):1722-9. PubMed ID: 16991167
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase and protein kinase A signaling pathways stimulate cholecystokinin transcription via activation of cyclic adenosine 3',5'-monophosphate response element-binding protein.
Hansen TV; Rehfeld JF; Nielsen FC
Mol Endocrinol; 1999 Mar; 13(3):466-75. PubMed ID: 10077003
[TBL] [Abstract][Full Text] [Related]
20. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation.
Quan ZW; Yang Y; Li JY; Gong W; Qin YY; Li SG
Biomed Pharmacother; 2010 Sep; 64(7):451-7. PubMed ID: 20359855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
